Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Didanosine (ddI) in AZT-Intolerant AIDS/ARC Patients
NCT00000672Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Primary completion
- Feb 1993
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of didanosine in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
didanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000672.